The outcomes of the STEP studies were impressive: Wegovy should be used for the chronic management of obesity or overweight with an existing weight-related medical problem such as diabetes, hypertension or sleep apnea
Review our guides on what to eat on tirzepatide and foods to avoid for detailed recommendations
This trial compared the recommended dosing schedule with alternative schedules
Tirzepatide was also superior to semaglutide in terms of weight loss, with mean reductions in body weight of -7.6 kg, -9.3 kg, and -11.2 kg for tirzepatide doses of 5 mg, 10 mg, and 15 mg, respectively, compared to -5.7 kg with semaglutide
Both medications helped most participants lose 5% or more of their body weight
Success depends on combining appropriate medication with this guide's dietary principles and lifestyle modifications